vorapaxar has been researched along with plerixafor* in 1 studies
1 other study(ies) available for vorapaxar and plerixafor
| Article | Year |
|---|---|
Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual Conference.
CHI's 17th International Tri-Conference on Molecular Medicine, held in San Francisco, included topics covering the drug discovery process, with an emphasis on lead optimization. This conference report highlights selected presentations on the development of several launched and investigational drugs, including Plerixafor, Trox-1 (CombinatoRX Inc), lorcaserin (Arena Pharmaceuticals Inc), vorapaxar (Merck & Co Inc) and ulimorelin (Tranzyme Pharma Inc). Topics: Animals; Anti-HIV Agents; Benzazepines; Benzylamines; Calcium Channel Blockers; Chemistry, Pharmaceutical; Coronary Artery Disease; Cyclams; Drug Discovery; Heterocyclic Compounds; Humans; Ileus; Lactones; Macrocyclic Compounds; Obesity; Pyridines; Receptor, PAR-1; Receptors, CXCR4; Receptors, Ghrelin; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists | 2010 |